Tag: percutaneous coronary intervention (PCI)

1. Patients without standard modifiable cardiovascular risk factors (SMuRFs) had a significantly higher all-cause mortality at 30 days after first ...

1. There was no significant difference in periprocedural myonecrosis between ticagrelor and clopidogrel among patients undergoing high-risk elective PCI. 2. ...

1. There was no significant difference in periprocedural myonecrosis between ticagrelor and clopidogrel among patients undergoing high-risk elective PCI. 2. ...

1. The rate of clinical events and all-cause mortality was similar in patients with drug-coated balloon therapy compared to those ...

1. The revalidated SYNTAX score II 2020 was effective at predicting 10-year all-cause mortality in patients undergoing percutaneous coronary intervention ...

1. In this modern population of Canadian patients with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI), the ...

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: ...

1. Colchicine given to patients after a myocardial infarction led to a significantly lower risk of death from cardiovascular causes, ...

1. Colchicine given to patients after a myocardial infarction led to a significantly lower risk of death from cardiovascular causes, ...

1. In patients with STEMI and multivessel coronary artery disease, those randomized to the complete revascularization group experienced lower rates ...